Humana Inc
NYSE:HUM

Watchlist Manager
Humana Inc Logo
Humana Inc
NYSE:HUM
Watchlist
Price: 289.42 USD 3.34% Market Closed
Market Cap: 34.8B USD
Have any thoughts about
Humana Inc?
Write Note

Intrinsic Value

The intrinsic value of one HUM stock under the Base Case scenario is 446.09 USD. Compared to the current market price of 289.42 USD, Humana Inc is Undervalued by 35%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HUM Intrinsic Value
446.09 USD
Undervaluation 35%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Humana Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for HUM cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about HUM?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Humana Inc

Provide an overview of the primary business activities
of Humana Inc.

What unique competitive advantages
does Humana Inc hold over its rivals?

What risks and challenges
does Humana Inc face in the near future?

Summarize the latest earnings call
of Humana Inc.

What significant events have occurred
in Humana Inc over the past months?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Humana Inc.

Provide P/S
for Humana Inc.

Provide P/E
for Humana Inc.

Provide P/B
for Humana Inc.

Show me price targets
for Humana Inc made by professional analysts.

What are the Revenue projections
for Humana Inc?

How accurate were the past Revenue estimates
for Humana Inc?

What are the Net Income projections
for Humana Inc?

How accurate were the past Net Income estimates
for Humana Inc?

What are the EPS projections
for Humana Inc?

How accurate were the past EPS estimates
for Humana Inc?

What are the EBIT projections
for Humana Inc?

How accurate were the past EBIT estimates
for Humana Inc?

Compare the revenue forecasts
for Humana Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Humana Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Humana Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Humana Inc compared to its peers.

Compare the P/E ratios
of Humana Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Humana Inc with its peers.

Analyze the financial leverage
of Humana Inc compared to its main competitors.

Show all profitability ratios
for Humana Inc.

Provide ROE
for Humana Inc.

Provide ROA
for Humana Inc.

Provide Net Margin
for Humana Inc.

Show all solvency ratios
for Humana Inc.

What is the historical Revenue growth
over the last 5 years for Humana Inc?

What is the historical Net Income growth
over the last 5 years for Humana Inc?

What is the current Free Cash Flow
of Humana Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Humana Inc.

Business Breakdown

Humana Inc. is a leading healthcare company based in the United States, providing a robust portfolio of health insurance products and services. Founded in 1961, Humana has evolved into a key player in the Medicaid and Medicare markets, delivering a range of options that cater to individuals, families, and employers. The company’s innovative approach to health and wellness, along with its growing focus on integrated care models, positions it uniquely to meet the needs of an aging population and an increasingly diverse healthcare landscape. With a mission centered around improving health outcomes, Humana has developed a reputation for leveraging technology and data analytics to enhance patient...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Humana Inc

Cash & Short-Term Investments 5.1B
Insurance Receivable 2.1B
PP&E 2.7B
Long-Term Investments 20.2B
Other Assets 19.9B
Insurance Policy Liabilities 11.1B
Long Term Debt 11.9B
Other Liabilities 9.4B
Earnings Calls

In the latest earnings call, Humana reported exceeding expectations, forecasting at least $16 in EPS for 2024 amidst a strong Medicare Advantage (MA) product performance, expecting 5% growth. The company prioritized strategic investments, balancing near-term earnings with future growth potential, particularly through expanded clinics and improved care management efficiencies. While aiming for margin expansion in 2025, Humana bears some risks related to market conditions and clinical ratings. They anticipate a minor headwind from dual disenrollments affecting revenues but remain optimistic about long-term profitability and revenue trajectory, with a growth outlook of 5% to 5.5% in MA for 2025.

What is Earnings Call?

Wall St
Price Targets

HUM Price Targets Summary
Humana Inc

Wall Street analysts forecast HUM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HUM is 299.89 USD with a low forecast of 249.47 USD and a high forecast of 414.75 USD.

Lowest
Price Target
249.47 USD
14% Downside
Average
Price Target
299.89 USD
4% Upside
Highest
Price Target
414.75 USD
43% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for HUM?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Nov 14, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for HUM is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest

HUM News

Other Videos

Profile

Humana Inc Logo
Humana Inc

Country

United States of America

Industry

Health Care

Market Cap

34.8B USD

Dividend Yield

1.22%

Description

Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 95,500 full-time employees. The firm operates through three reportable segments: Retail, Group and Specialty, and Healthcare Services. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts. The company also includes its contract to administer the limited income newly eligible transition (LI-NET), prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and long-term support services benefits. The Group and Specialty segment consists of employer group commercial fully insured medical and specialty health insurance benefits marketed to individuals and employer groups, including dental, vision, and other supplemental health benefits, as well as administrative services only products. The Healthcare Services segment includes pharmacy, provider, and home services, along with other services and capabilities to promote wellness and population health.

Contact

KENTUCKY
Louisville
500 W Main St
+15025801000.0
www.humana.com

IPO

1971-05-18

Employees

95 500

Officers

Chief Financial Officer
Ms. Susan Marie Diamond
Chief Legal Officer
Mr. Joseph C. Ventura
Strategic Advisor
Mr. Bruce Dale Broussard
President of Medicare & Medicaid
Mr. George Renaudin II
President of CenterWell
Dr. Sanjay K. Shetty M.B.A., M.D.
President, CEO & Director
Mr. James A. Rechtin M.B.A.
Show More
Senior VP, Chief Accounting Officer, Principal Accounting Officer & Controller
Mr. John-Paul William Felter
Senior VP & CTO
Mr. Eric Tagliere
Chief Information Officer
Mr. Samir M. Deshpande
Chief Administrative Officer
Mr. Timothy S. Huval
Show Less

See Also

Discover More
What is the Intrinsic Value of one HUM stock?

The intrinsic value of one HUM stock under the Base Case scenario is 446.09 USD.

Is HUM stock undervalued or overvalued?

Compared to the current market price of 289.42 USD, Humana Inc is Undervalued by 35%.

Back to Top